Hereditary hemorrhagic telangiectasia: epistaxis and hemoptysis
نویسندگان
چکیده
منابع مشابه
Hereditary hemorrhagic telangiectasia: epistaxis and hemoptysis.
A51-year-old woman with a 30-year history of recurrent epistaxis presented to the emergency department with a nosebleed. Her nosebleeds were initially mild but had gradually progressed in severity and frequency, and she had been admitted to hospital several times for cauterization. She also reported having very heavy menstrual periods in her 20s, for which she had had a hysterectomy at age 35. ...
متن کاملHereditary Hemorrhagic Telangiectasia: Presenting with Epistaxis
Osler-Weber-Rendu disease (OWRD) or Hereditary Hemorrhagic Telangiectasia (HHT) is a rare autosomal dominant disorder that causes muco-cutanesous and visceral vascular dysplasia and results in increased tendency for bleeding [1-4]. Patients with HHT may present with variety of symptoms and management differs accordingly. Epistaxis is the most common symptom of HHT and mucocutaneous telangiectas...
متن کاملRelationships between epistaxis, migraines, and triggers in hereditary hemorrhagic telangiectasia.
OBJECTIVES/HYPOTHESIS To identify whether relationships exist between epistaxis and migraines in hereditary hemorrhagic telangiectasia (HHT), to potentially provide further preventative and therapeutic options for the debilitating nosebleeds that are often very difficult to manage in clinical practice. STUDY DESIGN Study participants were recruited from a UK specialist service, and online fol...
متن کاملIs bevacizumab effective for reducing epistaxis in hereditary hemorrhagic telangiectasia?
BACKGROUND Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, often manifests with epistaxis. The disease spectrum is wide; some patients have small, irritating bleeds, whereas other patients require monthly blood transfusions. There are many medical and surgical interventions for epistaxis in HHT, but none have been established as a gold-standard treatment. ...
متن کاملDomiciliary floseal prevents admission for epistaxis in hereditary hemorrhagic telangiectasia.
INTRODUCTION Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, is an autosomal dominant bleeding disorder characterized by arteriovenous malformations and multiple telangiectasia affecting the skin, abdominal viscera, and mucosa. It affects approximately one in 5,000 to 8,000 people and presents with severe recurrent epistaxis, gastrointestinal bleeding, and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Medical Association Journal
سال: 2009
ISSN: 0820-3946,1488-2329
DOI: 10.1503/cmaj.081003